Chronic Migraine Study
Chronic migraine is defined as headaches on fifteen or more days per month, with at least half having migrainous qualities such as light- and/or sound sensitivity, nausea and/or vomiting. Chronic migraine effects 2-3% of the US population, and accounts for enormous disability (such as missed time from school, work, family and social life). So far in the US, only Botox is FDA approved for the preventive treatment of chronic migraine. More options are clearly needed.
Our chronic migraine studies currently include:
- “A Safety Study of LY2951742 in Participants With Migraine, With or Without Aura”.
- “Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic”
These and all studies at NEICR are free, and there is compensation provided for time and travel. To enroll or learn more fill out the form below or call us at 203-914-1903.
Use the form below to enroll